Allergic fungal rhinosinusitis: Perioperative management, prevention of recurrence, and role of steroids and antifungal agents
References (34)
- et al.
Allergenic fungi in allergic fungal sinusitis
Ann Allergy Asthma Immunol
(1997) - et al.
Local and systemic eosinophil activation in allergic fungal sinusitis (AFS)
Ann Allergy Asthma Immunol
(1997) - et al.
Allergic bipolaris sinusitis: Clinical and immunopathologic characteristics
J Allergy Clin Immunol
(1990) Allergic bronchopulmonary aspergillosis
J Allergy Clin Immunol
(1984)- et al.
Allergic Aspergillus sinusitis: A newly recognized form of sinusitis
J Allergy Clin Immunol
(1983) - et al.
Prognosis for allergic fungal sinusitis
Otolaryngol Head Neck Surg
(1997) - et al.
Immunotherapy for allergic fungal sinusitis: The second year
Otolaryngol Head Neck Surg
(1997) - et al.
Immunotherapy in the treatment of allergic fungal sinusitis
Otolaryngol Head Neck Surg
(1997) - et al.
Allergic fungal sinusitis due to Curvularia lunata
Hum Pathol
(1987) - et al.
The diagnosis and incidence of allergic fungal sinusitis
Mayo Clin Proc
(1999)
Unusual aspects of allergic bronchopulmonary fungal disease: Report of two cases due to Curvularia organisms associated with allergic fungal sinusitis
Hum Pathol
Allergie fungal sinusitis: Problems in diagnosis and treatment
Laryngoscope
Allergic fungal sinusitis secondary to dematia-ceous fungi—Curvularia lunata and Altermria
Otolaryngol Head Neck Surg
Antifungal activity against allergic fungal sinusitis organisms
Laryngoscope
The diagnosis of allergic fungal sinusitis
Otolaryngol Head Neck Surg
Allergic sino-orbital mycosis. A clinical and immunological study
JAMA
The Mayo clinic experience
Laryngoscope
Cited by (81)
Update on allergic fungal rhinosinusitis
2023, Annals of Allergy, Asthma and ImmunologyEffect of nebulized budesonide on decreasing the recurrence of allergic fungal rhinosinusitis
2017, American Journal of Otolaryngology - Head and Neck Medicine and SurgeryCitation Excerpt :The early side effects of oral steroids include psychosis, insomnia, weight gain, poorer control of blood glucose (in diabetic patients) and blood pressure (in hypertensive patients), and gastric distress from peptic ulcer disease. The long-term adverse effects include Cushing's syndrome, adrenal insufficiency, accelerated osteoporosis, glaucoma, cataract formation, and avascular necrosis of the hip [17]. Except the therapies mentioned, budesonide nasal irrigations also did not seem to cause HPA axis suppression, but it depends on the concentration [18,19].
Diagnostic Pathology: Head & Neck
2017, Diagnostic Pathology: Head and NeckDematiaceous Molds
2016, Infectious Disease Clinics of North AmericaCitation Excerpt :Therapy consists of surgery to remove the mucin, which is often tenacious, and systemic steroids. Antifungal therapy, usually in the form of itraconazole, may play a role in reducing the requirement for steroids; but this is not routinely recommended.52 Other azoles have only rarely been used for this disease.
Omalizumab therapy for refractory allergic fungal rhinosinusitis patients with moderate or severe asthma
2015, American Journal of Otolaryngology - Head and Neck Medicine and SurgeryCitation Excerpt :It accounts for approximately 7% of all chronic sinusitis cases requiring surgery [2]. The hallmark of this disease is the presence of thick peanut butter-like allergic mucin in the sinuses with histological findings of degenerating eosinophils, Charcot–Layden crystals and fungal hyphae without the evidence of sinonasal tissue invasion [2]. The typical AFRS patients are young, immunocompetent adults presenting with symptoms of CRS.
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi
2014, Clinical Microbiology and InfectionCitation Excerpt :Therapy consists of systemic steroids combined with surgical removal of the mucin (recommendation AII) [151–154]. The role of antifungal therapy, mostly azoles, is still under debate but may have a steroid-sparing effect (recommendation CIII) [152,153,155]. Recent reports indicate that oral triazole therapy can reduce symptoms of refractory sinusitis (recommendation BIII) [156–158].
- 1
From the Georgia Nasal & Sinus Institute, Savannah, Georgia